Glimepiride 3 Mg Tablet
Product Images NDC 72336-641

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride 3 Mg (NDC 72336-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifsa Drugs Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glimepiride-641 (72336641 1)

Label for Glimepiride Tablets USP 3 mg oral tablets by Lifsa Drugs LLC. The label indicates the dosage strength of 3 mg, packaging of 100 tablets, and instructions for once-daily use. It includes storage information, manufacturer and distributor details, and warnings to keep out of reach of children.*

FDA Label Image

Structure (72336641 2)

Chemical structure diagram of the active ingredient glimepiride, showing its molecular framework including amide, sulfonamide, and ring structures.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.